On 21 November 2016, the Senate referred the following matter to the Senate Community Affairs References Committee for inquiry and report:
Price regulation associated with the Prostheses List Framework.
The terms of reference are:
- the operation of relevant legislative and regulatory instruments;
- opportunities for creating a more competitive basis for the purchase and reimbursement of prostheses;
- the role and function of the Prostheses List Advisory Committee and its subcommittees;
- the cost of medical devices and prostheses for privately insured patients versus public hospital patients and patients in other countries;
- the impact the current Prostheses List Framework has on the affordability of private health insurance in Australia;
- the benefits of reforming the reference pricing system with Australian and international benchmarks;
- the benefits of any other pricing mechanism arrangements, including but not limited to those adopted by the Pharmaceutical Benefits Scheme, such as:
- mandatory price disclosure,
- value-based pricing, and
- reference pricing;
- price data and analytics to reveal the extent of, and where costs are being generated within, the supply chain, with a particular focus on the device categories of cardiac, Intra Ocular Lens Systems, hips, knees, spine and trauma;
- any interactions between Government decision-making and device manufacturers or stakeholders and their lobbyists;
- any implications for prostheses recipients of the National Disability Insurance Scheme transition period; and
- other related matters.
Submissions were sought by 30 January 2017. The reporting date is 30 March 2017.